Citation: K. Menton et al., FURTHER CHARACTERIZATION OF THE ANTAGONISTIC ACTION OF PYRIDYLISATOGEN ON THE ISOLATED TAENIA OF THE GUINEA-PIG CECUM, British Journal of Pharmacology, 122, 1997, pp. 49-49
Citation: K. Menton et al., DISRUPTION OF ENERGY-METABOLISM BY PYRIDYLISATOGEN IS MEDIATED BY THEMITOCHONDRIAL PERMEABILITY TRANSITION IN RAT HEPATIC MITOCHONDRIA, British Journal of Pharmacology, 122, 1997, pp. 112-112
Citation: A. Markham et al., PHEN WORKSHOP - A SURVEY OF METHODS OF TEACHING AND LEARNING IN UNDERGRADUATE PHARMACOLOGY WITHIN HIGHER-EDUCATION - 1996, British Journal of Pharmacology, 120, 1997, pp. 376-376
Citation: A. Markham et Kl. Goa, KETOTIFEN - A REVIEW OF ITS THERAPEUTIC EFFICACY IN DERMATOLOGICAL DISORDERS, CLINICAL IMMUNOTHERAPEUTICS, 5(5), 1996, pp. 400-411
Citation: A. Markham, POTENTIAL IMPACTS OF CLIMATE-CHANGE ON ECOSYSTEMS - A REVIEW OF IMPLICATIONS FOR POLICY-MAKERS AND CONSERVATION BIOLOGISTS, Climate research, 6(2), 1996, pp. 179-191
Citation: Mi. Wilde et A. Markham, ONDANSETRON - A REVIEW OF ITS PHARMACOLOGY AND PRELIMINARY CLINICAL FINDINGS IN NOVEL APPLICATIONS, Drugs, 52(5), 1996, pp. 773-794
Citation: Lr. Wiseman et A. Markham, IRINOTECAN - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN THE MANAGEMENT OF ADVANCED COLORECTAL-CANCER, Drugs, 52(4), 1996, pp. 606-623
Citation: A. Markham et D. Faulds, ROPIVACAINE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN REGIONAL ANESTHESIA, Drugs, 52(3), 1996, pp. 429-449
Citation: R. Davis et al., CIPROFLOXACIN - AN UPDATED REVIEW OF ITS PHARMACOLOGY, THERAPEUTIC EFFICACY AND TOLERABILITY, Drugs, 51(6), 1996, pp. 1019-1074
Citation: Cj. Dunn et A. Markham, EPOETIN-BETA - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL USE IN THE MANAGEMENT OF ANEMIA ASSOCIATED WITH CHRONIC-RENAL-FAILURE (VOL 51, PG 314, 1996), Drugs, 51(5), 1996, pp. 894-894
Citation: B. Fulton et A. Markham, MYCOPHENOLATE MOFETIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND CLINICAL EFFICACY IN RENAL-TRANSPLANTATION, Drugs, 51(2), 1996, pp. 278-298
Citation: Cj. Dunn et A. Markham, EPOETIN-BETA - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL USE IN THE MANAGEMENT OF ANEMIA ASSOCIATED WITH CHRONIC-RENAL-FAILURE, Drugs, 51(2), 1996, pp. 299-318
Citation: A. Markham et D. Mctavish, CLARITHROMYCIN AND OMEPRAZOLE - AS HELICOBACTER-PYLORI ERADICATION THERAPY IN PATIENTS WITH HELICOBACTER-PYLORI-ASSOCIATED GASTRIC DISORDERS, Drugs, 51(1), 1996, pp. 161-178
Citation: K. Menton et A. Markham, THE ABILITY OF SPERMINE TO REDUCE THE PROTECTIVE ACTION OF CYCLOSPORINE-A WITHIN RAT HEPATIC MITOCHONDRIA, British Journal of Pharmacology, 119, 1996, pp. 270-270
Citation: P. Gundkalli et al., THE ANTIARRHYTHMIC EFFECTS OF ISCHEMIC MYOCARDIAL PRECONDITIONING - AROLE FOR PROTEIN-KINASE-C, British Journal of Pharmacology, 118, 1996, pp. 11-11
Authors:
ROBINSON PA
KAZEMI H
LEEK J
HUME W
MARKHAM A
Citation: Pa. Robinson et al., CHROMOSOMAL LOCALIZATION OF TERMINAL DIFFERENTIATION GENES DIFFERENTIALLY EXPRESSED BETWEEN KERATOCYST AND NORMAL ORAL EPITHELIA, Journal of dental research, 74(3), 1995, pp. 824-824
Citation: S. Noble et A. Markham, CYCLOSPORINE - A REVIEW OF THE PHARMACOKINETIC PROPERTIES, CLINICAL EFFICACY AND TOLERABILITY OF A MICROEMULSION-BASED FORMULATION (NEORAL), Drugs, 50(5), 1995, pp. 924-941
Citation: A. Markham et Rn. Brogden, CEFIXIME - A REVIEW OF ITS THERAPEUTIC EFFICACY IN LOWER RESPIRATORY-TRACT INFECTIONS, Drugs, 49(6), 1995, pp. 1007-1022
Citation: A. Markham et Hm. Bryson, EPOETIN ALFA - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN NONRENAL APPLICATIONS, Drugs, 49(2), 1995, pp. 232-254